Literature DB >> 221274

Cyclic nucleotides and neuromuscular transmission.

F G Standaert, K L Dretchen.   

Abstract

A review of the research on cyclic nucleotides and neuromuscular transmission suggests that cAMP is involved in the release of transmitter from motor nerve endings. Lipid-soluble derivations of cAMP cause depolarization of unstimulated nerve endings and prolong the after potentials of stimulated nerve endings. They also increase the frequency of miniature end plate potentials and increase the quantal content of stimulus evoked end plate potentials. Similar effects are produced by compounds that activate adenylate cyclase or inhibit phosphodiesterase. The responses to the derivatives of cAMP and activators of cyclase are enhanced by inhibitors of phosphodiesterase and prevented by compounds that block the flux of calcium into nerve endings. There is no evidence that suggests that cyclic nucleotides are involved in the postjunctional response to transmitter. Thus, it seems likely that cAMP is involved in the regulation of calcium in motor nerve endings and the exocytosis of transmitter. Additional study should expand our knowledge of neuromuscular transmission and contribute to an understanding of the functions of cyclic nucleotides in other synapses.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221274

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  10 in total

1.  Role of cyclic nucleotides in mediating the nitric oxide (II) effects on transmitter release and the electrogenesis of motor nerve endings.

Authors:  A V Yakovlev; G F Sitdikova; A L Zefirov
Journal:  Dokl Biol Sci       Date:  2002 Jan-Feb

2.  Facilitation of frog neuromuscular transmission by sodium fluoride.

Authors:  T Hattori; H Maehashi
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

3.  Ionic mechanism of a voltage-dependent current elicited by cyclic AMP.

Authors:  T C Pellmar
Journal:  Cell Mol Neurobiol       Date:  1981-03       Impact factor: 5.046

4.  The role of cyclic AMP and its protein kinase in mediating acetylcholine release and the action of adenosine at frog motor nerve endings.

Authors:  J K Hirsh; E M Silinsky; C S Solsona
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

5.  The effects of an adenylate cyclase inhibitor on the electrophysiological correlates of neuromuscular transmission in the frog.

Authors:  E M Silinsky; S M Vogel
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

6.  On the mechanism by which adenosine receptor activation inhibits the release of acetylcholine from motor nerve endings.

Authors:  E M Silinsky
Journal:  J Physiol       Date:  1984-01       Impact factor: 5.182

7.  Blockade of acetylcholine release at the motor endplate by a polypeptide from the venom of Phoneutria nigriventer.

Authors:  C Souccar; M do C Gonçalo; A J Lapa; L R Troncone; I Lebrun; F Magnoli
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

8.  E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype.

Authors:  Deborah L Clarke; Mark A Giembycz; Hema J Patel; Maria G Belvisi
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

9.  3H-noradrenaline release from rat neocortical slices in the absence of extracellular Ca2+ and its presynaptic alpha 2-adrenergic modulation. A study on the possible role of cyclic AMP.

Authors:  A N Schoffelmeer; A H Mulder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-07       Impact factor: 3.000

10.  Paradoxical facilitation of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by isoprenaline.

Authors:  M G Belvisi; H J Patel; T Takahashi; P J Barnes; M A Giembycz
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.